NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









C16 Biosciences

C16 Biosciences

Private
New York City, New YorkEnergy & Sustainabilityhttps://www.c16bio.com/

Last Round

Grant

Jan 24, 2024

Total Funding Raised

$28.5M

Company Overview

C16 Biosciences is a biotechnology company that has developed a proprietary biomanufacturing platform to produce sustainable alternatives to palm oil and other fats.

Sector

Energy & Sustainability

Verticals

Biotechnology, Sustainable Materials, Fashion & Beauty, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

precision fermentationbio-based ingredientssustainable palm oilbiomanufacturinglab-grown fatsalternative lipidssynthetic biologyclean beauty ingredientsbio-based emollientsfood techsupply chain resiliencedeforestation-freeB2B ingredient supplierfermentation platformalt-protein

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

C16 Biosciences Comparables

Compare C16 Biosciences with similar companies based on industry and business-model similarity.

C16 Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NoPalm Ingredients
89%
Xylome Corporation
88%
Clean Food Group
87%

C16 Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 24, 2024
AcceleratorOct 17, 2023
VC RoundMar 22, 2023
Series AMar 2, 2020
SeedNov 21, 2018

C16 Biosciences Investors

Notable investors and investment history

C16 Biosciences investors
InvestorRounds
Elemental ImpactAccelerator, Grant
Gates FoundationGrant
Breakthrough Energy VenturesSeries A
WaldencastSeries A
The Bill & Melinda Gates Foundation TrustGrant
Sound VenturesSeries A
Y CombinatorSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 17, 2023

    $1M raised from Elemental Impact

  • Mar 22, 2023

    $5M round raised

C16 Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

C16 Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about C16 Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range27
Year Founded2017
Last FundingJan 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.